Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535 - Wikidata - awgldk - TriplyDB

Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535

Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535

http://www.wikidata.org/entity/Q27324314

about

Liver cancer stem cell markers: Progression and therapeutic implications Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment Targeting cancer stem cells by using the nanoparticles FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesis N-Aryl benzenesulfonamide inhibitors of [3H]-thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinoma.Long non-coding RNA regulation of liver cancer stem cell self-renewal offers new therapeutic targeting opportunities.CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment CONSORT: Sam68 Is Directly Regulated by MiR-204 and Promotes the Self-Renewal Potential of Breast Cancer Cells by Activating the Wnt/Beta-Catenin Signaling Pathway.WNT/β-Catenin signaling pathway regulates non-tumorigenesis of human embryonic stem cells co-cultured with human umbilical cord mesenchymal stem cells.Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines.Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization.Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.Promising new strategies for hepatocellular carcinoma.The evolving concept of liver cancer stem cells.Curcumin Enhanced Busulfan-Induced Apoptosis through Downregulating the Expression of Survivin in Leukemia Stem-Like KG1a Cells Cancer stem cells in hepatocellular carcinomas MiR-92a promotes stem cell-like properties by activating Wnt/β-catenin signaling in colorectal cancer.FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway.Stemness-Related Markers in Cancer.IKKβ is a β-catenin kinase that regulates mesenchymal stem cell differentiation.Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance.

P2860

Q26751026-32947707-EF9B-4B1B-9B1A-6B16CA4A4E92 Q26774623-9B762273-DB4B-4D0B-BF12-FACE5B69439C Q26783590-20C79B49-5B90-460E-89ED-FE28F9BB5C0C Q33715651-B73836C2-27D1-490F-9791-F8ED5459FD27 Q35804238-09D703FE-DD02-4882-8165-C4E1082A5342 Q35967478-87B7C3C8-2FA5-4D4C-9965-E08B06E6442A Q36292211-A85A0416-1214-4AAF-AB51-D6A06A544F20 Q36905769-EB18B171-82D8-40AC-88C6-FB14AE21F43A Q37002076-491D9670-543A-429B-A1A6-18FE164E5613 Q37044081-D5FDD390-26CF-4696-8EB7-3C31E0F14E20 Q37190326-6A312663-ACEB-46C4-AD49-34EB219237F3 Q37226034-90D5A0EE-E205-4E0C-9778-0029B63873FB Q37623698-43841A40-E976-4727-9DD1-5ABC6E18F38A Q38450711-047FC4FC-EC21-4946-AD50-5AF991642C84 Q38739189-8A9056EC-294C-4C96-BEAB-6EED70522E67 Q38748583-027D9777-FB52-4D75-B59F-D99EB28AF37E Q38788971-98168C83-9B98-499B-A475-EB606145DD14 Q38854734-E70F362E-BB04-493B-B238-17FC9648DE66 Q38936589-930EAF29-C83E-47F9-9036-9BB95E9D626D Q39109959-4C037B77-927F-4E63-88AD-E19A9FC8D5EB Q41861089-C5B1C4CD-4EF6-47D6-ABD8-39AE1997C89D Q42655441-05D751B3-0F27-4C27-BA3E-9A2EDE034DBC Q47106409-9480CE43-2E49-431F-A5D1-D92A5005E56E Q47135534-D300FEB2-B31F-4CB3-92D1-8E59E80F1765 Q47176774-3F0513C7-B3BF-4436-850E-82C007E4ECF6 Q49788187-2DA267B9-A4CB-4898-ACAD-C3643BC354C0 Q50977776-F35284B2-8F59-4B8E-844E-65AD7C56B037 Q55428498-0AA51A26-93A3-4E85-AC6B-7D12A609D32A

P2860

Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535

http://www.wikidata.org/entity/Q27324314

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@ast

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@en

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@nl

type

label

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@ast

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@en

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@nl

prefLabel

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@ast

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@en

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@nl

P1433

Q27324314-00DBB277-FC5F-4988-8C16-99508A4CF802

P1476

Q27324314-590357BA-87E9-4508-A75C-44F71F541C96

P2093

Q27324314-47554A9B-617E-4C08-9EF0-5180F76CDE4A

Q27324314-48A46729-B277-4D93-BE72-1B60315D6277

Q27324314-4AA5E20B-6A81-4B71-A5F0-119387231527

Q27324314-5DF62CD7-720B-4D0D-8AC3-8A3FA54F60AB

Q27324314-5E41184B-4878-4516-A9F8-F1A883BC8BF2

Q27324314-82AE2193-84AB-4DA5-802A-240450FC9197

Q27324314-8CA1A6FF-DD79-4C18-9263-011053F16666

Q27324314-92A78F06-51C6-4D29-8903-F2891F972F78

Q27324314-A18128F8-32C6-4C2F-98C1-380579C65A76

Q27324314-B4BBDD4A-764D-49F2-AA31-8DC09F340A6D

P2860

Q27324314-0861FEC7-E9A8-4020-B096-C42A1E5196BC

Q27324314-197E4821-493C-4AE9-B6FA-BD2185B83DBF

Q27324314-240475D0-4C66-46D1-9923-125CF0A79126

Q27324314-2DC933EE-E9E2-486E-A6FC-B680C2A7DB0B

Q27324314-2F3CFC14-D0AE-4858-9FEB-27ECB1897C03

Q27324314-44C80254-21BF-45DC-A6C4-DD864598E6F5

Q27324314-5042892E-83A6-48AC-9703-5CD2C855A852

Q27324314-5050E466-045A-4776-9B5C-6A09C53BBD8A

Q27324314-59F23A92-3D29-48C3-84BA-2F92293450C5

Q27324314-5BB4F89D-BDF9-4CD0-8639-5F095033CB30

P304

Q27324314-3A7161C4-0B0C-44E2-B265-9836BC748AE1

P31

Q27324314-4D24E7C8-D09F-4103-81C1-8E6E290058E8

P356

Q27324314-F1D0FC39-AC0D-419F-975E-BFF0B78015F4

P407

Q27324314-D2184EB0-DDE2-4021-B2E9-B0D205100ACC

P433

Q27324314-BE5A8837-A68B-4E41-A28C-1C9AF822F01D

P478

Q27324314-6BB10388-451E-4303-9467-3D3E84957BB8

P50

Q27324314-251865A5-35D2-46BE-9BD6-D4ECFA200A68

P577

Q27324314-91D4C041-0842-46BD-8DD0-71C16B372D34

P5875

Q27324314-61E7BB6D-AA8B-4726-B4CA-9CB1FFC39816

P698

Q27324314-0878964D-9FCD-4CB9-9A51-14CFFB56E9A3

P932

Q27324314-FEFDC7A1-6CA3-4162-82D8-4081AF1A5EA2

P356

JOURNAL.PONE.0099272

P1433

P1476

Targeting the Wnt/β-catenin si ...... arcinoma cell lines with FH535

@en

P2093

B Mark Evers

http://www.w3.org/2001/XMLSchema#string

Changguo Chen

http://www.w3.org/2001/XMLSchema#string

Donald A Cohen

http://www.w3.org/2001/XMLSchema#string

Erin Maynard

http://www.w3.org/2001/XMLSchema#string

Jieyun Jiang

http://www.w3.org/2001/XMLSchema#string

Karyn A Esser

http://www.w3.org/2001/XMLSchema#string

Malay Shah

http://www.w3.org/2001/XMLSchema#string

Michael F Daily

http://www.w3.org/2001/XMLSchema#string

Roberto Galuppo

http://www.w3.org/2001/XMLSchema#string

Roberto Gedaly

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of c-MYC as a target of the APC pathway

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion

Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma

Functional interaction of beta-catenin with the transcription factor LEF-1

Hepatocellular carcinoma

Growth of human hepatoma cells lines with differentiated functions in chemically defined medium

Primary liver cancer: worldwide incidence and trends

P304

e99272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0099272

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263208886

http://www.w3.org/2001/XMLSchema#string

P698

24940873

http://www.w3.org/2001/XMLSchema#string

P932

4062395

http://www.w3.org/2001/XMLSchema#string